# Human Intestinal Peptides Evaluation and Research

> **NCT02532829** · — · UNKNOWN · sponsor: **Turkish Metabolic Surgery Foundation** · enrollment: 240 (estimated)

## Conditions studied

- Obesity
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** blood sample analysis

## Key facts

- **NCT ID:** NCT02532829
- **Lead sponsor:** Turkish Metabolic Surgery Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-11
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02532829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02532829, "Human Intestinal Peptides Evaluation and Research". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02532829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*